PT-141 and Cialis are both used for sexual dysfunction, but they solve fundamentally different problems. Understanding this distinction is critical — choosing the wrong one means it simply will not work for your specific issue.
How They Work
PT-141 (Bremelanotide) is a synthetic melanocortin peptide that acts in the central nervous system. It activates melanocortin-4 (MC4R) receptors in the hypothalamus, the brain region that governs sexual desire and arousal. By stimulating these receptors, PT-141 increases the neurological "want" — the actual feeling of sexual desire. It does not affect blood flow directly.
Cialis (Tadalafil) is a phosphodiesterase type 5 (PDE5) inhibitor that works peripherally. It blocks the enzyme PDE5 in penile smooth muscle tissue, allowing cyclic GMP to accumulate and produce sustained vasodilation. The result is increased blood flow to the penis, enabling and maintaining an erection. Cialis does not increase desire — it enables the physical response when desire is already present.
What the Research Shows
PT-141 was FDA-approved in 2019 as Vyleesi for premenopausal women with HSDD. Clinical trials (RECONNECT) showed statistically significant increases in desire and reductions in distress related to low sexual desire. In men, studies show PT-141 produces erections even in those who failed PDE5 inhibitors, suggesting a central mechanism of action that bypasses the vascular pathway entirely.
Cialis has over two decades of clinical data. It is FDA-approved for erectile dysfunction and benign prostatic hyperplasia (BPH). The LUTS/BPH studies demonstrated that daily low-dose tadalafil (5 mg) improves both urinary symptoms and erectile function.
Side Effects and Tolerability
PT-141 side effects include nausea (the most common, occurring in approximately 40% of users), flushing, headache, and injection site reactions. Nausea is typically transient and mild but can be dose-limiting. An anti-nausea medication taken 30 minutes prior can help.
Cialis side effects include headache, dyspepsia, back pain, nasal congestion, and flushing. Rare but serious risks include priapism and sudden vision or hearing changes. It is contraindicated with nitrates due to the risk of severe hypotension.
How to Choose
Choose PT-141 if: your primary issue is low sexual desire rather than an inability to achieve erection. This applies to both men and women. If you have adequate blood flow but simply do not feel "in the mood," PT-141 targets the root neurological cause.
Choose Cialis if: your issue is erectile dysfunction — you have the desire but cannot achieve or maintain an erection. Cialis is also a good choice if you want daily low-dose coverage (the 5 mg daily protocol) that provides around-the-clock readiness.
Consider both if: you experience both low desire and erectile dysfunction, which is common in aging men. PT-141 restores the desire centrally while Cialis ensures the physical response peripherally.